Natural variation in the μ-opioid gene OPRM1 predicts increased pain on third day after thoracotomy

Clin J Pain. 2012 Nov-Dec;28(9):747-54. doi: 10.1097/AJP.0b013e3182442b1c.

Abstract

Objectives: The mechanism whereby acute postsurgical pain can persist and become chronic remains unknown. Thoracotomy is a common procedure with a high incidence of long-term pain for which acute postsurgical pain is an established risk factor. Therefore, the genetic basis of elevations in acute postsurgical pain after thoracotomy was investigated.

Methods: A cohort of thoracotomy patients participating in an ongoing trial of outcomes after cancer were enrolled. A standard combined general and epidural anesthetic and surgical approach were used. All patients received a standardized postoperative epidural analgesia regimen. Postoperatively, pain scores were determined and blood was collected for genotyping. Our a priori hypothesis was that variability of genes involved in nociception and analgesic therapy would predict pain score ≥3 of 10 on the third postoperative day.

Results: Ninety patients with pain and genotyping data on postoperative day 3 were examined. We found no association between markers in COMT, COX1, COX2, and TRPV1 and postoperative pain. We demonstrated several statistically significant associations with 4 single nucleotide polymorphism markers in OPRM1 (odds ratio, 95% confidence intervals): rs634479 (0.4, 0.17, 0.97), rs499796 (0.35, 0.13, 0.92), rs548646 (0.47, 0.23, 0.97), and rs679987 (0.1, 0.01, 0.84). From these, we inferred 2 haplotype blocks in OPRM1 where both had a frequency of 9% and P=0.03 and 0.04. Previously published functional single nucleotide polymorphisms in OPRM1 and COMT were not associated with increased pain on the third postoperative day.

Discussion: We identified previously unpublished haplotypes of the OPRM1 receptor that predicted increases in self-reported pain on the third postoperative day after thoracotomy. These findings require replication and further refinement before their impact on patient care can be determined.

MeSH terms

  • Aged
  • Analgesics / therapeutic use
  • Catechol O-Methyltransferase / genetics
  • Chi-Square Distribution
  • Cohort Studies
  • Cyclooxygenase 1 / genetics
  • Cyclooxygenase 2 / genetics
  • Dose-Response Relationship, Drug
  • Female
  • Genetic Predisposition to Disease / genetics*
  • Genotype
  • Humans
  • Male
  • Middle Aged
  • Outcome Assessment, Health Care
  • Pain Measurement
  • Pain, Postoperative / drug therapy
  • Pain, Postoperative / etiology*
  • Pain, Postoperative / genetics*
  • Polymorphism, Single Nucleotide / genetics*
  • Predictive Value of Tests
  • Receptors, Opioid, mu / genetics*
  • TRPV Cation Channels / genetics
  • Thoracotomy / adverse effects*

Substances

  • Analgesics
  • OPRM1 protein, human
  • Receptors, Opioid, mu
  • TRPV Cation Channels
  • TRPV1 protein, human
  • Cyclooxygenase 1
  • Cyclooxygenase 2
  • PTGS1 protein, human
  • PTGS2 protein, human
  • Catechol O-Methyltransferase